Mette Langaas
Overview
Explore the profile of Mette Langaas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
426
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
De Martin Topranin V, Wiig-Fisketjon A, Botten E, Dalen H, Langaas M, Bye A
Eur J Prev Cardiol
. 2025 Mar;
PMID: 40063873
Aims: Current risk prediction models, such as the Norwegian NORRISK 2, explain only a modest proportion of cardiovascular disease (CVD) incidence. This study aimed to develop improved sex-specific models for...
2.
de Soysa A, Langaas M, Grill V, Martins C, Lovold Mostad I
PLoS One
. 2025 Jan;
20(1):e0312815.
PMID: 39792913
Associations between variants in the FTO locus and plasma concentrations of appetite related hormones are inconsistent, and might not work in a dose dependent fashion in people with obesity. Moreover,...
3.
Nordeidet A, Klevjer M, Wisloff U, Langaas M, Bye A
Physiol Genomics
. 2023 Aug;
55(10):440-451.
PMID: 37575066
Low cardiorespiratory fitness, measured as maximal oxygen uptake (V̇o), is associated with all-cause mortality and disease-specific morbidity and mortality and is estimated to have a large genetic component (∼60%). However,...
4.
Lauvsnes A, Hansen T, Ankill S, Bae S, Grawe R, Braund T, et al.
JMIR Form Res
. 2023 Jun;
7:e45254.
PMID: 37351934
Background: Patients with substance use disorders (SUDs) are at increased risk for symptom deterioration following treatment, with up to 60% resuming substance use within the first year posttreatment. Substance use...
5.
Pedersen T, Fenstad M, Wallenius M, Hetlelid E, Follestad T, Langaas M, et al.
Clin Exp Rheumatol
. 2023 May;
41(9):1838-1846.
PMID: 37246773
Objectives: Systemic lupus erythematosus (SLE) pregnancies are considered high-risk due to risk of disease flare and pregnancy complications. A more in-depth understanding of the immunological alterations in SLE patients during...
6.
Exploring Dietary Intake in Adults with Severe Obesity and Associations with the rs9939609 Genotypes
de Soysa A, Martins C, Langaas M, Grill V, Lovold Mostad I
Curr Dev Nutr
. 2023 May;
7(2):100032.
PMID: 37180087
Background: Few have studied the associations between rs9939609 genotypes in the obesity candidate locus and energy and nutrient intakes and meal frequencies in adults with severe obesity. We are unaware...
7.
Johnsen P, Bakke O, Bjornland T, DeWan A, Langaas M
Stat Med
. 2023 Apr;
42(16):2746-2759.
PMID: 37094813
We investigate saddlepoint approximations of tail probabilities of the score test statistic in logistic regression for genome-wide association studies. The inaccuracy in the normal approximation of the score test statistic...
8.
Johnsen P, Strumke I, Langaas M, DeWan A, Riemer-Sorensen S
PLoS Comput Biol
. 2023 Mar;
19(3):e1010963.
PMID: 36917581
Estimating feature importance, which is the contribution of a prediction or several predictions due to a feature, is an essential aspect of explaining data-based models. Besides explaining the model itself,...
9.
Roislien J, Langaas M
Tidsskr Nor Laegeforen
. 2022 Dec;
142(18).
PMID: 36511742
No abstract available.
10.
Lauvsnes A, Grawe R, Langaas M
Brain Sci
. 2022 Jul;
12(7).
PMID: 35884763
Patients with severe substance use disorders are often characterized by neurocognitive impairments and elevated mental health symptom load, typically associated with craving intensity and substance use relapse. There is a...